{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:02:24Z","timestamp":1791576144166,"version":"4.3.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,8,10]],"date-time":"2016-08-10T00:00:00Z","timestamp":1470787200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81570369"],"award-info":[{"award-number":["81570369"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81571515"],"award-info":[{"award-number":["81571515"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Program for Changjiang Scholars and Innovative Research Team in University","award":["IRT0935"],"award-info":[{"award-number":["IRT0935"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Toxicol"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s12012-016-9381-z","type":"journal-article","created":{"date-parts":[[2016,8,10]],"date-time":"2016-08-10T09:24:09Z","timestamp":1470821049000},"page":"267-276","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Contrary microRNA Expression Pattern Between Fetal and Adult Cardiac Remodeling: Therapeutic Value for Heart Failure"],"prefix":"10.1007","volume":"17","author":[{"given":"Hualin","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimin","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,10]]},"reference":[{"issue":"12","key":"9381_CR1","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrcardio.2011.154","volume":"8","author":"O Gjesdal","year":"2011","unstructured":"Gjesdal, O., Bluemke, D. A., & Lima, J. A. (2011). Cardiac remodeling at the population level\u2014Risk factors, screening, and outcomes. Nature Reviews Cardiology, 8(12), 673\u2013685.","journal-title":"Nature Reviews Cardiology"},{"issue":"13","key":"9381_CR2","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1056\/NEJMra072139","volume":"358","author":"JA Hill","year":"2008","unstructured":"Hill, J. A., & Olson, E. N. (2008). Cardiac plasticity. New England Journal of Medicine, 358(13), 1370\u20131380.","journal-title":"New England Journal of Medicine"},{"issue":"10","key":"9381_CR3","doi-asserted-by":"crossref","first-page":"e0140273","DOI":"10.1371\/journal.pone.0140273","volume":"10","author":"S Balasubramanian","year":"2015","unstructured":"Balasubramanian, S., et al. (2015). Dasatinib attenuates pressure overload induced cardiac fibrosis in a murine transverse aortic constriction model. PLoS One, 10(10), e0140273.","journal-title":"PLoS One"},{"issue":"8","key":"9381_CR4","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/nrcardio.2015.71","volume":"12","author":"CM Greco","year":"2015","unstructured":"Greco, C. M., & Condorelli, G. (2015). Epigenetic modifications and noncoding RNAs in cardiac hypertrophy and failure. Nature Reviews Cardiology, 12(8), 488\u2013497.","journal-title":"Nature Reviews Cardiology"},{"issue":"4","key":"9381_CR5","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1161\/CIRCRESAHA.116.303549","volume":"116","author":"T Thum","year":"2015","unstructured":"Thum, T., & Condorelli, G. (2015). Long noncoding RNAs and microRNAs in cardiovascular pathophysiology. Circulation Research, 116(4), 751\u2013762.","journal-title":"Circulation Research"},{"issue":"5824","key":"9381_CR6","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1126\/science.1139089","volume":"316","author":"E Rooij van","year":"2007","unstructured":"van Rooij, E., et al. (2007). Control of stress-dependent cardiac growth and gene expression by a microRNA. Science, 316(5824), 575\u2013579.","journal-title":"Science"},{"issue":"7","key":"9381_CR7","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.cjca.2013.02.001","volume":"29","author":"V Thakur","year":"2013","unstructured":"Thakur, V., et al. (2013). Diagnosis and management of fetal heart failure. Canadian Journal of Cardiology, 29(7), 759\u2013767.","journal-title":"Canadian Journal of Cardiology"},{"issue":"Suppl 2","key":"9381_CR8","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1017\/S104795111500089X","volume":"25","author":"JC Huhta","year":"2015","unstructured":"Huhta, J. C. (2015). Diagnosis and treatment of foetal heart failure: Foetal echocardiography and foetal hydrops. Cardiology in the Young, 25(Suppl 2), 100\u2013106.","journal-title":"Cardiology in the Young"},{"issue":"4","key":"9381_CR9","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1097\/GRF.0b013e3181fdffd9","volume":"53","author":"JC Huhta","year":"2010","unstructured":"Huhta, J. C., & Paul, J. J. (2010). Doppler in fetal heart failure. Clinical Obstetrics and Gynecology, 53(4), 915\u2013929.","journal-title":"Clinical Obstetrics and Gynecology"},{"issue":"4","key":"9381_CR10","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1016\/j.ijcard.2013.08.130","volume":"169","author":"K Zhou","year":"2013","unstructured":"Zhou, K., et al. (2013). Evaluation of therapeutic effect and cytokine change during transplacental Digoxin treatment for fetal heart failure associated with fetal tachycardia, a case-control study. International Journal of Cardiology, 169(4), e62\u2013e64.","journal-title":"International Journal of Cardiology"},{"key":"9381_CR11","first-page":"360687","volume":"2014","author":"Y Li","year":"2014","unstructured":"Li, Y., et al. (2014). The study of fetal rat model of intra-amniotic isoproterenol injection induced heart dysfunction and phenotypic switch of contractile proteins. BioMed Research International, 2014, 360687.","journal-title":"BioMed Research International"},{"issue":"2","key":"9381_CR12","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s12012-014-9277-8","volume":"15","author":"J Fang","year":"2015","unstructured":"Fang, J., et al. (2015). Antithetical regulation of alpha-myosin heavy chain between fetal and adult heart failure though shuttling of HDAC5 regulating YY-1 function. Cardiovascular Toxicology, 15(2), 147\u2013156.","journal-title":"Cardiovascular Toxicology"},{"issue":"1","key":"9381_CR13","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"DW Huang","year":"2009","unstructured":"Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009). Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature Protocols, 4(1), 44\u201357.","journal-title":"Nature Protocols"},{"issue":"3","key":"9381_CR14","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1161\/CIRCULATIONAHA.107.687947","volume":"116","author":"T Thum","year":"2007","unstructured":"Thum, T., et al. (2007). microRNAs in the human heart: A clue to fetal gene reprogramming in heart failure [Erratum appears in Circulation. 2007 Jul 17;116(3):e135]. Circulation, 116(3), 258\u2013267.","journal-title":"Circulation"},{"issue":"5","key":"9381_CR15","doi-asserted-by":"crossref","first-page":"H1340","DOI":"10.1152\/ajpheart.00592.2009","volume":"298","author":"Q Li","year":"2010","unstructured":"Li, Q., et al. (2010). NFATc4 is negatively regulated in miR-133a-mediated cardiomyocyte hypertrophic repression. American Journal of Physiology Heart and Circulatory Physiology, 298(5), H1340\u2013H1347.","journal-title":"American Journal of Physiology Heart and Circulatory Physiology"},{"issue":"4","key":"9381_CR16","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/HYPERTENSIONAHA.109.139519","volume":"55","author":"DL Dong","year":"2010","unstructured":"Dong, D. L., et al. (2010). Reciprocal repression between microRNA-133 and calcineurin regulates cardiac hypertrophy: A novel mechanism for progressive cardiac hypertrophy. Hypertension, 55(4), 946\u2013952.","journal-title":"Hypertension"},{"issue":"5","key":"9381_CR17","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nm1582","volume":"13","author":"A Care","year":"2007","unstructured":"Care, A., et al. (2007). microRNA-133 controls cardiac hypertrophy. Nature Medicine, 13(5), 613\u2013618.","journal-title":"Nature Medicine"},{"issue":"2","key":"9381_CR18","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1161\/CIRCRESAHA.108.182535","volume":"104","author":"RF Duisters","year":"2009","unstructured":"Duisters, R. F., et al. (2009). MiR-133 and miR-30 regulate connective tissue growth factor: Implications for a role of microRNAs in myocardial matrix remodeling. Circ Res., 104(2), 170\u2013178. 6p following 178.","journal-title":"Circ Res."},{"issue":"2","key":"9381_CR19","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/jcp.22939","volume":"227","author":"G Castoldi","year":"2012","unstructured":"Castoldi, G., et al. (2012). MiR-133a regulates collagen 1A1: Potential role of miR-133a in myocardial fibrosis in angiotensin II-dependent hypertension. Journal of Cellular Physiology, 227(2), 850\u2013856.","journal-title":"Journal of Cellular Physiology"},{"issue":"23","key":"9381_CR20","doi-asserted-by":"crossref","first-page":"7231","DOI":"10.1073\/pnas.1501327112","volume":"112","author":"AM Curtis","year":"2015","unstructured":"Curtis, A. M., et al. (2015). Circadian control of innate immunity in macrophages by miR-155 targeting Bmal1. Proceedings of the National Academy of Sciences, 112(23), 7231\u20137236.","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"16","key":"9381_CR21","first-page":"2349","volume":"18","author":"JL Bao","year":"2014","unstructured":"Bao, J. L., & Lin, L. (2014). MiR-155 and miR-148a reduce cardiac injury by inhibiting NF-kappaB pathway during acute viral myocarditis. European Review for Medical and Pharmacological Sciences, 18(16), 2349\u20132356.","journal-title":"European Review for Medical and Pharmacological Sciences"},{"issue":"10","key":"9381_CR22","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1161\/CIRCRESAHA.114.303784","volume":"114","author":"HY Seok","year":"2014","unstructured":"Seok, H. Y., et al. (2014). Loss of microRNA-155 protects the heart from pathological cardiac hypertrophy. Circulation Research, 114(10), 1585\u20131595.","journal-title":"Circulation Research"},{"issue":"6","key":"9381_CR23","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.immuni.2014.03.014","volume":"40","author":"TM Escobar","year":"2014","unstructured":"Escobar, T. M., et al. (2014). MiR-155 activates cytokine gene expression in Th17 cells by regulating the DNA-binding protein Jarid2 to relieve polycomb-mediated repression. Immunity, 40(6), 865\u2013879.","journal-title":"Immunity"},{"issue":"13","key":"9381_CR24","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1161\/CIRCULATIONAHA.112.001357","volume":"128","author":"S Heymans","year":"2013","unstructured":"Heymans, S., et al. (2013). Macrophage microRNA-155 promotes cardiac hypertrophy and failure. Circulation, 128(13), 1420\u20131432.","journal-title":"Circulation"},{"issue":"3","key":"9381_CR25","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cmet.2013.08.009","volume":"18","author":"H Azzouzi el","year":"2013","unstructured":"el Azzouzi, H., et al. (2013). The hypoxia-inducible microRNA cluster miR-199a approximately 214 targets myocardial PPARdelta and impairs mitochondrial fatty acid oxidation. Cell Metabolism, 18(3), 341\u2013354.","journal-title":"Cell Metabolism"},{"issue":"7","key":"9381_CR26","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1161\/CIRCRESAHA.108.193102","volume":"104","author":"S Rane","year":"2009","unstructured":"Rane, S., et al. (2009). Downregulation of miR-199a derepresses hypoxia-inducible factor-1alpha and Sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes. Circulation Research, 104(7), 879\u2013886.","journal-title":"Circulation Research"},{"issue":"2","key":"9381_CR27","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/jcp.22217","volume":"225","author":"XW Song","year":"2010","unstructured":"Song, X. W., et al. (2010). microRNAs are dynamically regulated in hypertrophic hearts, and miR-199a is essential for the maintenance of cell size in cardiomyocytes. Journal of Cellular Physiology, 225(2), 437\u2013443.","journal-title":"Journal of Cellular Physiology"},{"issue":"10","key":"9381_CR28","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1093\/eurheartj\/ehq369","volume":"32","author":"A Haghikia","year":"2011","unstructured":"Haghikia, A., et al. (2011). Signal transducer and activator of transcription 3-mediated regulation of miR-199a-5p links cardiomyocyte and endothelial cell function in the heart: A key role for ubiquitin-conjugating enzymes. European Heart Journal, 32(10), 1287\u20131297.","journal-title":"European Heart Journal"},{"issue":"12","key":"9381_CR29","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1038\/ncb2126","volume":"12","author":"PA da Costa Martins","year":"2010","unstructured":"da Costa Martins, P. A., et al. (2010). microRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin\/NFAT signalling. Nature Cell Biology, 12(12), 1220\u20131227.","journal-title":"Nature Cell Biology"},{"key":"9381_CR30","doi-asserted-by":"crossref","first-page":"18351","DOI":"10.1038\/srep18351","volume":"5","author":"M Sun","year":"2015","unstructured":"Sun, M., et al. (2015). microRNA-214 mediates isoproterenol-induced proliferation and collagen synthesis in cardiac fibroblasts. Scientific Reports, 5, 18351.","journal-title":"Scientific Reports"},{"key":"9381_CR31","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1186\/s12967-015-0725-4","volume":"13","author":"Q Duan","year":"2015","unstructured":"Duan, Q., et al. (2015). microRNA regulation of unfolded protein response transcription factor XBP1 in the progression of cardiac hypertrophy and heart failure in vivo. Journal of Translational Medicine, 13, 363.","journal-title":"Journal of Translational Medicine"},{"issue":"8","key":"9381_CR32","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1002\/jcp.24942","volume":"230","author":"Q Duan","year":"2015","unstructured":"Duan, Q., et al. (2015). microRNA-214 is upregulated in heart failure patients and suppresses XBP1-mediated endothelial cells angiogenesis. Journal of Cellular Physiology, 230(8), 1964\u20131973.","journal-title":"Journal of Cellular Physiology"},{"issue":"4","key":"9381_CR33","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.bbrc.2013.05.079","volume":"436","author":"T Yang","year":"2013","unstructured":"Yang, T., et al. (2013). microRNA-214 provokes cardiac hypertrophy via repression of EZH2. Biochemical and Biophysical Research Communications, 436(4), 578\u2013584.","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"12","key":"9381_CR34","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1161\/CIRCULATIONAHA.110.982918","volume":"123","author":"T Hosoda","year":"2011","unstructured":"Hosoda, T., et al. (2011). Human cardiac stem cell differentiation is regulated by a mircrine mechanism. Circulation, 123(12), 1287\u20131296.","journal-title":"Circulation"},{"issue":"4","key":"9381_CR35","doi-asserted-by":"crossref","first-page":"339","DOI":"10.4161\/rna.28300","volume":"11","author":"J Wang","year":"2014","unstructured":"Wang, J., et al. (2014). MiR-499 protects cardiomyocytes from H2O 2-induced apoptosis via its effects on Pdcd4 and Pacs2. RNA Biology, 11(4), 339\u2013350.","journal-title":"RNA Biology"},{"issue":"1","key":"9381_CR36","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1161\/RES.0b013e3182582523","volume":"111","author":"SR Houser","year":"2012","unstructured":"Houser, S. R., et al. (2012). Animal models of heart failure: A scientific statement from the American Heart Association. Circulation Research, 111(1), 131\u2013150.","journal-title":"Circulation Research"},{"issue":"1","key":"9381_CR37","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1161\/01.RES.75.1.105","volume":"75","author":"JR Teerlink","year":"1994","unstructured":"Teerlink, J. R., Pfeffer, J. M., & Pfeffer, M. A. (1994). Progressive ventricular remodeling in response to diffuse isoproterenol-induced myocardial necrosis in rats. Circulation Research, 75(1), 105\u2013113.","journal-title":"Circulation Research"},{"issue":"14","key":"9381_CR38","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1161\/01.CIR.101.14.1634","volume":"101","author":"RJ Lefkowitz","year":"2000","unstructured":"Lefkowitz, R. J., Rockman, H. A., & Koch, W. J. (2000). Catecholamines, cardiac beta-adrenergic receptors, and heart failure. Circulation, 101(14), 1634\u20131637.","journal-title":"Circulation"},{"issue":"8","key":"9381_CR39","first-page":"BR309","volume":"18","author":"Y Hou","year":"2012","unstructured":"Hou, Y., et al. (2012). Beta-adrenoceptor regulates miRNA expression in rat heart. Medical Science Monitor, 18(8), BR309\u2013BR314.","journal-title":"Medical Science Monitor"},{"key":"9381_CR40","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.biopha.2015.02.030","volume":"71","author":"HQ Sang","year":"2015","unstructured":"Sang, H. Q., et al. (2015). microRNA-133a improves the cardiac function and fibrosis through inhibiting Akt in heart failure rats. Biomedicine and Pharmacotherapy, 71, 185\u2013189.","journal-title":"Biomedicine and Pharmacotherapy"},{"issue":"48","key":"9381_CR41","doi-asserted-by":"crossref","first-page":"18255","DOI":"10.1073\/pnas.0608791103","volume":"103","author":"E Rooij van","year":"2006","unstructured":"van Rooij, E., et al. (2006). A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proceedings of the National Academy of Sciences, 103(48), 18255\u201318260.","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"1","key":"9381_CR42","doi-asserted-by":"crossref","first-page":"e84188","DOI":"10.1371\/journal.pone.0084188","volume":"9","author":"BW Wang","year":"2014","unstructured":"Wang, B. W., et al. (2014). microRNA-208a increases myocardial fibrosis via endoglin in volume overloading heart. PLoS One, 9(1), e84188.","journal-title":"PLoS One"},{"issue":"3\u20134","key":"9381_CR43","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10741-007-9034-1","volume":"12","author":"M Rajabi","year":"2007","unstructured":"Rajabi, M., et al. (2007). Return to the fetal gene program protects the stressed heart: a strong hypothesis. Heart Failure Reviews, 12(3\u20134), 331\u2013343.","journal-title":"Heart Failure Reviews"},{"issue":"24","key":"9381_CR44","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1161\/hc4901.100526","volume":"104","author":"P Razeghi","year":"2001","unstructured":"Razeghi, P., et al. (2001). Metabolic gene expression in fetal and failing human heart. Circulation, 104(24), 2923\u20132931.","journal-title":"Circulation"},{"issue":"8","key":"9381_CR45","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1161\/01.CIR.103.8.1089","volume":"103","author":"K Kinugawa","year":"2001","unstructured":"Kinugawa, K., et al. (2001). Signaling pathways responsible for fetal gene induction in the failing human heart: Evidence for altered thyroid hormone receptor gene expression. Circulation, 103(8), 1089\u20131094.","journal-title":"Circulation"},{"key":"9381_CR46","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1749-6632.2009.05100.x","volume":"1188","author":"H Taegtmeyer","year":"2010","unstructured":"Taegtmeyer, H., Sen, S., & Vela, D. (2010). Return to the fetal gene program: A suggested metabolic link to gene expression in the heart. Annals of the New York Academy of Sciences, 1188, 191\u2013198.","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"2","key":"9381_CR47","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.cardiores.2003.11.014","volume":"61","author":"M Bilsen van","year":"2004","unstructured":"van Bilsen, M., et al. (2004). Metabolic remodelling of the failing heart: The cardiac burn-out syndrome? Cardiovascular Research, 61(2), 218\u2013226.","journal-title":"Cardiovascular Research"},{"issue":"11","key":"9381_CR48","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/nm1116","volume":"10","author":"L Cheng","year":"2004","unstructured":"Cheng, L., et al. (2004). Cardiomyocyte-restricted peroxisome proliferator-activated receptor-delta deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy. Nature Medicine, 10(11), 1245\u20131250.","journal-title":"Nature Medicine"},{"issue":"21","key":"9381_CR49","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1161\/CIRCULATIONAHA.105.551457","volume":"112","author":"L Lee","year":"2005","unstructured":"Lee, L., et al. (2005). Metabolic modulation with perhexiline in chronic heart failure: A randomized, controlled trial of short-term use of a novel treatment. Circulation, 112(21), 3280\u20133288.","journal-title":"Circulation"},{"issue":"6","key":"9381_CR50","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1161\/CIRCRESAHA.112.268128","volume":"111","author":"SC Kolwicz Jr","year":"2012","unstructured":"Kolwicz, S. C, Jr., et al. (2012). Cardiac-specific deletion of acetyl CoA carboxylase 2 prevents metabolic remodeling during pressure-overload hypertrophy. Circulation Research, 111(6), 728\u2013738.","journal-title":"Circulation Research"}],"container-title":["Cardiovascular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12012-016-9381-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-016-9381-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-016-9381-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-016-9381-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T10:28:44Z","timestamp":1498213724000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12012-016-9381-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,10]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["9381"],"URL":"https:\/\/doi.org\/10.1007\/s12012-016-9381-z","relation":{},"ISSN":["1530-7905","1559-0259"],"issn-type":[{"value":"1530-7905","type":"print"},{"value":"1559-0259","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,10]]}}}